SE9803929D0 - Antiviral formulation - Google Patents
Antiviral formulationInfo
- Publication number
- SE9803929D0 SE9803929D0 SE9803929A SE9803929A SE9803929D0 SE 9803929 D0 SE9803929 D0 SE 9803929D0 SE 9803929 A SE9803929 A SE 9803929A SE 9803929 A SE9803929 A SE 9803929A SE 9803929 D0 SE9803929 D0 SE 9803929D0
- Authority
- SE
- Sweden
- Prior art keywords
- antiviral
- weight
- antiviral formulation
- prophylaxis
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
DE69923584T DE69923584T2 (de) | 1998-11-18 | 1999-11-12 | Antivirale zusammensetzungen welche propylenglykol und isopropyl-alkansäureester enthalten |
CNB998133825A CN1160128C (zh) | 1998-11-18 | 1999-11-12 | 含有丙二醇和异丙基链烷酸酯的抗病毒制剂 |
IL14270299A IL142702A0 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
NZ511832A NZ511832A (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
AT99972109T ATE288283T1 (de) | 1998-11-18 | 1999-11-12 | Antivirale zusammensetzungen welche propylenglykol und isopropyl-alkansäureester enthalten |
SI9930733T SI1131104T1 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
DK99972109T DK1131104T3 (da) | 1998-11-18 | 1999-11-12 | Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester |
EP99972109A EP1131104B1 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
AU14364/00A AU772435B2 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
PCT/SE1999/002043 WO2000029027A1 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
CA002351463A CA2351463C (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
KR1020017006232A KR100608963B1 (ko) | 1998-11-18 | 1999-11-12 | 프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제 |
PT99972109T PT1131104E (pt) | 1998-11-18 | 1999-11-12 | Formulacoes antivirais compreendendo propilenoglicol e um ester de acido isopropilalcanoico |
JP2000582073A JP2002529520A (ja) | 1998-11-18 | 1999-11-12 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
ES99972109T ES2233104T3 (es) | 1998-11-18 | 1999-11-12 | Formulaciones antivirales que comprenden propilenglicol y un ester isopropilico de acido alcanoico. |
TW088119865A TW589191B (en) | 1998-11-18 | 1999-11-15 | Topical compositions comprising antiinflammatory glucocorticoid and nucleoside analogue antiviral agent in pharmaceutical carrier |
EG146899A EG23853A (en) | 1998-11-18 | 1999-11-16 | Antiviral glucocorticoid formulation comprising propylene glycol and ispropyl alkanoic acid esters |
MYPI99004979A MY122397A (en) | 1998-11-18 | 1999-11-16 | Acyclic antiviral and hydrocortisone combination comprising propylene glycol and alkanoic acid ester |
ARP990105846A AR023705A1 (es) | 1998-11-18 | 1999-11-17 | COMPOSICIoN ToPICA QUE COMPRENDE EL GLUCOCORTICOIDE ANTIINFLAMATORIO HIDROCORTISONA Y UN AGENTE ANTIVIRAL ANALOGO DE NUCLEOSIDO ACICLOVIR Y EL USO DE LA MISMA |
IL142702A IL142702A (en) | 1998-11-18 | 2001-04-19 | Antiviral formulations consisting of propylene glycol ester of alkanoic isopropyl acid |
ZA200103335A ZA200103335B (en) | 1998-11-18 | 2001-04-24 | Antiviral formulations comprising propylene glycol and an isopropyl alkonoic acid ester. |
HK02104279.2A HK1042440B (zh) | 1998-11-18 | 2002-06-05 | 含有丙二醇和異丙基鏈烷酸酯的抗病毒製劑 |
US10/334,487 US7223387B2 (en) | 1998-11-18 | 2002-12-30 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
JP2011087438A JP5420583B2 (ja) | 1998-11-18 | 2011-04-11 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9803929D0 true SE9803929D0 (sv) | 1998-11-18 |
Family
ID=20413320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1131104B1 (tr) |
JP (2) | JP2002529520A (tr) |
KR (1) | KR100608963B1 (tr) |
CN (1) | CN1160128C (tr) |
AR (1) | AR023705A1 (tr) |
AT (1) | ATE288283T1 (tr) |
AU (1) | AU772435B2 (tr) |
CA (1) | CA2351463C (tr) |
DE (1) | DE69923584T2 (tr) |
DK (1) | DK1131104T3 (tr) |
EG (1) | EG23853A (tr) |
ES (1) | ES2233104T3 (tr) |
HK (1) | HK1042440B (tr) |
IL (2) | IL142702A0 (tr) |
MY (1) | MY122397A (tr) |
NZ (1) | NZ511832A (tr) |
PT (1) | PT1131104E (tr) |
SE (1) | SE9803929D0 (tr) |
TW (1) | TW589191B (tr) |
WO (1) | WO2000029027A1 (tr) |
ZA (1) | ZA200103335B (tr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2319626T3 (es) | 2001-11-19 | 2009-05-11 | Medigene Ag | Farmaco para el tratamiento de enfermedades tumorales y de la piel virales. |
BRPI0415215B8 (pt) | 2003-10-09 | 2021-05-25 | Medigene Ag | uso de polifenol na preparação de medicamento |
JP4972062B2 (ja) * | 2008-03-17 | 2012-07-11 | メディヴィル・アクチエボラーグ | 抗ウイルス製剤 |
ES2955089T3 (es) * | 2018-08-17 | 2023-11-28 | Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi | Composición tópica estable en fase que comprende aciclovir e hidrocortisona |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ1966A1 (fr) * | 1995-02-06 | 2002-10-15 | Astra Ab | Combinaison pharmaceutique nouvelle. |
US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
-
1998
- 1998-11-18 SE SE9803929A patent/SE9803929D0/xx unknown
-
1999
- 1999-11-12 IL IL14270299A patent/IL142702A0/xx active IP Right Grant
- 1999-11-12 WO PCT/SE1999/002043 patent/WO2000029027A1/en active IP Right Grant
- 1999-11-12 NZ NZ511832A patent/NZ511832A/en not_active IP Right Cessation
- 1999-11-12 AU AU14364/00A patent/AU772435B2/en not_active Expired
- 1999-11-12 DE DE69923584T patent/DE69923584T2/de not_active Expired - Lifetime
- 1999-11-12 ES ES99972109T patent/ES2233104T3/es not_active Expired - Lifetime
- 1999-11-12 AT AT99972109T patent/ATE288283T1/de active
- 1999-11-12 EP EP99972109A patent/EP1131104B1/en not_active Expired - Lifetime
- 1999-11-12 DK DK99972109T patent/DK1131104T3/da active
- 1999-11-12 KR KR1020017006232A patent/KR100608963B1/ko active IP Right Grant
- 1999-11-12 JP JP2000582073A patent/JP2002529520A/ja active Pending
- 1999-11-12 PT PT99972109T patent/PT1131104E/pt unknown
- 1999-11-12 CN CNB998133825A patent/CN1160128C/zh not_active Expired - Lifetime
- 1999-11-12 CA CA002351463A patent/CA2351463C/en not_active Expired - Lifetime
- 1999-11-15 TW TW088119865A patent/TW589191B/zh not_active IP Right Cessation
- 1999-11-16 MY MYPI99004979A patent/MY122397A/en unknown
- 1999-11-16 EG EG146899A patent/EG23853A/xx active
- 1999-11-17 AR ARP990105846A patent/AR023705A1/es active IP Right Grant
-
2001
- 2001-04-19 IL IL142702A patent/IL142702A/en not_active IP Right Cessation
- 2001-04-24 ZA ZA200103335A patent/ZA200103335B/en unknown
-
2002
- 2002-06-05 HK HK02104279.2A patent/HK1042440B/zh not_active IP Right Cessation
-
2011
- 2011-04-11 JP JP2011087438A patent/JP5420583B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100608963B1 (ko) | 2006-08-09 |
ZA200103335B (en) | 2002-07-24 |
JP2011157392A (ja) | 2011-08-18 |
IL142702A (en) | 2006-07-05 |
CA2351463C (en) | 2009-10-13 |
ATE288283T1 (de) | 2005-02-15 |
DE69923584D1 (de) | 2005-03-10 |
CN1160128C (zh) | 2004-08-04 |
NZ511832A (en) | 2003-09-26 |
MY122397A (en) | 2006-04-29 |
AU1436400A (en) | 2000-06-05 |
WO2000029027A1 (en) | 2000-05-25 |
AU772435B2 (en) | 2004-04-29 |
EG23853A (en) | 2007-11-06 |
EP1131104A1 (en) | 2001-09-12 |
EP1131104B1 (en) | 2005-02-02 |
ES2233104T3 (es) | 2005-06-01 |
IL142702A0 (en) | 2002-03-10 |
TW589191B (en) | 2004-06-01 |
DE69923584T2 (de) | 2006-03-23 |
PT1131104E (pt) | 2005-03-31 |
CN1326364A (zh) | 2001-12-12 |
HK1042440B (zh) | 2005-04-29 |
CA2351463A1 (en) | 2000-05-25 |
KR20010075720A (ko) | 2001-08-09 |
AR023705A1 (es) | 2002-09-04 |
JP5420583B2 (ja) | 2014-02-19 |
DK1131104T3 (da) | 2005-03-14 |
HK1042440A1 (en) | 2002-08-16 |
JP2002529520A (ja) | 2002-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2211389A1 (en) | Novel pharmaceutical combination | |
MY107341A (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
HUP0301121A2 (hu) | Külsżleges gyógyszerkészítmények és gyógykezelések | |
CA2141953A1 (en) | Pharmaceutical formulations of interleukin-1 inhibitors | |
BR9306768A (pt) | Artigo e estrutura absorventes extensíveis | |
AU1937395A (en) | Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic | |
PT716600E (pt) | Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas | |
CA2136331A1 (en) | New pharmaceutical uses of krill enzymes | |
CA2190505A1 (en) | Use of gel formulations as dressing agents | |
IT1263013B (it) | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. | |
HK1024422A1 (en) | Antimicrobial cosmetic compositions | |
RS50046B (sr) | Farmaceutske kompozicije tizoksanida i nitazoksanida | |
ES2065647T3 (es) | Empleo cosmetico de una composicion que tiene una actividad antieritematosa. | |
IT1272149B (it) | Composizione farmeceutiche ad attivita' analgesica | |
CA2417935A1 (en) | Anti-inflammatory medicament | |
AU1876792A (en) | Pharmacologically enhanced formulations | |
ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
SE9803929D0 (sv) | Antiviral formulation | |
RU95113437A (ru) | (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью | |
IL107755A0 (en) | Pharmacuetical compositions for the treatment and prophylaxis of parasitic infections | |
ITRM990339A0 (it) | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali deriva | |
AU3435189A (en) | Topically applied gold organic complex | |
IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
ATE102934T1 (de) | Fluorierte flavon-essigsaeure. | |
ITMI911122A0 (it) | Composizioni per la terapia topica delle ustioni |